 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
1 to 6 of 6 results |
|
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
Jagust W. on NEWS: Does ApoE4 Risk Begin in the Womb?, I think this is consistent with a theme that is gradually emerging in the literature: ApoE has... 8 Jan 2013.
|
 |
 |
 |
 |
 |
Jagust W. on NEWS: Functional Connectivity Predicts Aβ Deposition in Mice, This is another very interesting paper from David Holtzman's lab, continuing a very interesting... 29 Mar 2012.
|
 |
 |
 |
 |
 |
Jagust W. on PAPER: Dickerson BC. et al., 2012, This paper is very interesting, and another in a series by Brad Dickerson showing that his... 4 Jan 2012.
|
 |
 |
 |
 |
 |
Jagust W. on NEWS: What Do Clinicians Say? Peers Welcome Revised Criteria, I was a member of the MCI committee and helped define the biomarker criteria in that draft... 4 Aug 2010.
|
 |
 |
 |
 |
 |
Jagust W. on PAPER: Buckner RL. et al., 2009, This paper takes the previous associations between brain function and β amyloid deposition a... 13 Feb 2009.
|
 |
 |
 |
 |
 |
Jagust W. on NEWS: One Thumb Up on Dietary Fat, One Down on Vitamins, Two Down on Estrogen, It is difficult to understand why the results of the Rotterdam study and ours are different. The... 24 Feb 2003.
|
 |
 |
 |
 |
 |
 |
1 to 6 of 6 results |
|
 |
|
 |
 |
 |
 |
 |
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 The ALS Forum is a web-based collaborative effort to bring together valuable ALS-related resources for use by researchers worldwide in both academia and industry-based settings.
|
 |
 |
 |
 |
 |
 |
|
 |
 |
 |
 |
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
 |
 |
 |
 |
 |
Should the FDA be allowed to use data from overseas clinical trials? |
 |
 |
 |
 |
 |
|
 |
 |
 |
 |
 |
Absolutely, we are running out of viable subjects in the U.S. |
 |
 |
 |
 |
 |
 |
9 |
 |
 |
 |
 |
 |
|
 |
 |
 |
 |
 |
Yes, so long as the data is reliable |
 |
 |
 |
 |
 |
 |
31 |
 |
 |
 |
 |
 |
|
 |
 |
 |
 |
 |
No, the trials are not as rigorous |
 |
 |
 |
 |
 |
 |
3 |
 |
 |
 |
 |
 |
|
 |
 |
 |
 |
 |
No, the data should be repeated in the U.S. |
 |
 |
 |
 |
 |
 |
5 |
 |
 |
 |
 |
 |
|
 |
 |
 |
 |
 |
No, the drug sponsors are just trying to cut corners |
 |
 |
 |
 |
 |
 |
3 |
 |
 |
 |
 |
 |
|
 |
 |
 |
 |
 |
Responses: 51 |
 |
 |
 |
 |
 |
|
 |
 |
 |
 |
|
 |
 |
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
 |
 |
 |
 |
 |
Archived Polls |
 |
 |
 |
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |

Antibodies
Cell Lines
Collaborators
Papers
Research Participants
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |

|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
 |